ClinicalTrials.govpublic full text
Venetoclax and Azacitidine for the Management of Molecular Relapse/Progression in Adult NPM1-mutated Acute Myeloid Leukemia
acute myeloid leukemia, acute myeloid leukemia, in relapse, npm1 mutation, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 903056
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.